Alar Pharmaceuticals Inc. (TPEX:6785)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
137.00
-3.50 (-2.49%)
May 8, 2026, 1:30 PM CST
Market Cap9.15B +14.6%
Revenue (ttm)3.00M -52.7%
Net Income-112.77M
EPS-1.69
Shares Out66.80M
PE Ration/a
Forward PEn/a
Dividend0.10 (0.07%)
Ex-Dividend DateJun 10, 2025
Volume102,502
Average Volume156,526
Open139.00
Previous Close140.50
Day's Range135.50 - 139.00
52-Week Range129.00 - 317.00
Beta0.18
RSI28.03
Earnings DateMay 15, 2026

About Alar Pharmaceuticals

Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan. [Read more]

Sector Healthcare
Founded 2016
Employees 27
Stock Exchange Taipei Exchange
Ticker Symbol 6785
Full Company Profile

Financial Performance

Financial Statements